What the Restasis MultiDose TV commercial - Reduced Tear Production is about.
Restasis MultiDose is a prescription eye drop medication used to treat a common condition known as dry eye. Dry eye occurs when the eyes do not produce enough tears, leading to discomfort, irritation, and inflammation. In the Restasis MultiDose TV spot titled 'Reduced Tear Production', the focus is on how the medication can effectively treat this condition.
The commercial begins with a woman sitting at her desk, looking uncomfortable and rubbing her eyes. A voiceover explains that dry eye is a common condition, affecting millions of people. It then goes on to describe how Restasis MultiDose works by reducing inflammation and increasing tear production, resulting in long-lasting relief from dry eye symptoms.
The visual elements of the ad show the woman using the eye drops, with a close-up of the bottle and instructions on how to use them properly. The woman then becomes more comfortable and relaxed, no longer rubbing her eyes or straining to see her computer screen.
The commercial also includes a disclaimer stating that the medication should not be used by those with eye infections or allergies and that potential side effects should be discussed with a doctor.
In conclusion, Restasis MultiDose TV Spot, 'Reduced Tear Production' effectively demonstrates how the medication can alleviate dry eye symptoms and improve the overall quality of life for those living with this condition.
Restasis MultiDose TV commercial - Reduced Tear Production produced for
Restasis
was first shown on television on July 3, 2017.
Frequently Asked Questions about restasis multidose tv spot, 'reduced tear production'
It's the same preservative-free RESTASIS® formulation doctors have prescribed 6.4 million times since 2003,* in a patented bottle design. Compared to RESTASIS® single-use vials, RESTASIS MultiDose ® is more compact, uses less plastic in packaging, and is the same price in comparison to a package of single-use vials.
Restasis is an immunosuppressive medication that works to reduce inflammation in the tear glands, helping to prevent further damage. Some people also report recovered tear production after using this medication for long periods of time.
by Drugs.com
One bottle of Restasis MultiDose (cyclosporine ophthalmic emulsion) contains a little over 120 doses/drops. One drop of Restasis MultiDose should be administered into each eye twice daily, amounting to 4 drops total, which means that one bottle should last a little longer than 30 days.
Take one drop in each eye twice a day, every day, at least 12 hours apart. It may take 3 months for some patients to begin noticing an increase in tear production, with significant increase in tear production at 6 months. Individual results may vary.
Cequa Eye Drops
Like Restasis and Xiidra, Cequa is prescribed to be taken every 12 hours, or twice a day. Cequa is similar to Restasis in the fact that it is composed of 0.09% Cyclosporine. It therefore functions to decrease inflammation and increase natural tear production.
Similar to brand-name Restasis, this generic version is available as packs of 30 and 60 single-use vials, containing 0.5 mg of cyclosporine in every 1 mL. Keep in mind, there still isn't a generic available for the multiple use bottle, Restasis MultiDose.
Ophthalmic cyclosporine is used to increase tear production in people with dry eye disease. Cyclosporine is in a class of medications called immunomodulators. It works by decreasing swelling in the eye to allow for tear production.
The active ingredient, cyclosporine, is an immune inhibitor. It limits the production of enzymes that cause inflammation. Blocking eye inflammation that way helps increase tear fluid production, improving eye moisture.
RESTASIS MultiDose™ is the first and only FDA-approved preservative-free, prescription eye drop in the U.S. to be available in a multidose bottle. RESTASIS® was accessible only in single-use vials, since its launch in 2003 until now.
The bottom line
It can take up to 6 months for it to work. But some people may start feeling relief within a month of starting it. Each dose lasts for about 12 hours. You can take Restasis while taking lubricant eye drops.
ophthalmic emulsion contains: Active: cyclosporine 0.05%. Inactives: glycerin; castor oil; polysorbate 80; carbomer copolymer type A; purified water; and sodium hydroxide to adjust pH.
RESTASIS MultiDose™ is the first and only FDA-approved preservative-free, prescription eye drop in the U.S. to be available in a multidose bottle. RESTASIS® was accessible only in single-use vials, since its launch in 2003 until now.